
# Title 21 - Food and Drugs
## Chapter I - Food and Drug Administration, Department of Health and Human Services
### Subchapter H - Medical Devices
#### PART 862 - CLINICAL CHEMISTRY AND CLINICAL TOXICOLOGY DEVICES
##### Subpart B - Clinical Chemistry Test Systems
###### ยง 862.1622 Prognostic test for assessment of liver related disease progression.
####### e.g.,

(iv) Detailed information on device performance, including any limitations to the data generated in the clinical study(ies) and information on device performance in relevant subgroups (severity of liver disease at the beginning of the observation period) observed in the clinical study(ies).

(v) Information on the analytical performance of the device, including demonstration of reproducibility across multiple sites and multiple reagent lots, or an alternative reproducibility study design determined to be appropriate by FDA.
